Abstract |
Carvedilol (20 mg/kg, bid) or vehicle was given to rats surviving a myocardial infarction (MI) 24 h (n = 409). In rats with large MI, carvedilol partially preserved left ventricular (LV) function and intrinsic myocardial contractility and reactivity to beta- adrenergic stimulation. Carvedilol led to scar thickening, increased LV hypertrophy, and decreased cardiac fibrosis but did not prevent LV dilatation. Carvedilol reduced cardiac expression of interleukin-1beta but did not prevent cardiac fetal gene re-expression or modify cardiac oxidative stress. Despite these beneficial effects, carvedilol decreased survival (38.8%, versus vehicle, 50.6%) due to excessive early mortality. Thus, post-MI carvedilol has many beneficial effects, however, in this study it increased post-MI mortality, perhaps due to excessive hypotension.
|
Authors | Ying Tung Sia, Thomas G Parker, James N Tsoporis, Peter Liu, Albert Adam, Jean L Rouleau |
Journal | Journal of cardiovascular pharmacology
(J Cardiovasc Pharmacol)
Vol. 39
Issue 1
Pg. 73-87
(Jan 2002)
ISSN: 0160-2446 [Print] United States |
PMID | 11743230
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Adrenergic beta-Antagonists
- Carbazoles
- Cytokines
- Propanolamines
- Carvedilol
|
Topics |
- Adrenergic beta-Antagonists
(pharmacology)
- Animals
- Carbazoles
(pharmacology)
- Carvedilol
- Cytokines
(drug effects, metabolism)
- Fibrosis
- Gas Chromatography-Mass Spectrometry
- Hemodynamics
(drug effects)
- In Vitro Techniques
- Male
- Myocardial Contraction
(drug effects)
- Myocardial Infarction
(metabolism, mortality, physiopathology)
- Myocardium
(pathology)
- Nuclease Protection Assays
- Oxidative Stress
(drug effects)
- Papillary Muscles
(drug effects)
- Propanolamines
(pharmacology)
- Rats
- Rats, Wistar
- Ventricular Function, Left
(drug effects)
- Ventricular Remodeling
(drug effects)
|